All-In Podcast Features Four Investor Pitches on MGM, Talen Energy, Aktis, GEODNET
🔒 The letter grade, factuality score, and political-lean rating for this report are part of CladFacts Premium. The full report below is free to read.
Topics in This Edition
Summary
The broadcast covers a live pitch competition hosted by the All-In Podcast with four investors presenting top ideas. Aaron Cowen of Suvretta Capital pitches MGM Resorts highlighting Barry Diller's stake and bid plus Japan and Dubai expansion options. Dan Dreyfus of Bornite Capital pitches Talen Energy as undervalued power assets benefiting from AI-driven demand. Oleg Nodelman of EcoR1 Capital pitches Aktis Oncology's radiopharmaceutical platform for cancer. Kyle Samani pitches the GEODNET token and its decentralized RTK network for robotics and precision location. Segments include audience questions, bestie feedback, rankings, and a live audience vote.
Editorial Assessment
The pitches draw on publicly available company information and timely developments such as the June 2026 Diller bid for MGM, but many upside scenarios rely on unproven catalysts and multiples without detailed risk adjustments or comparables. Framing emphasizes asymmetric reward while downplaying execution, regulatory, clinical, and competitive risks across sectors. Viewers receive limited counter-analysis or third-party valuation context beyond participant opinions. The event format blends entertainment with investment discussion but treats speculative projections as near-term opportunities. Overall quality is solid for a podcast format yet requires listeners to independently verify financial models and timelines.
Key Moments
Barry Diller owns 26% of MGM and bid $48.30 per share in a go-private deal
Confirmed in multiple June 2026 reports from NYT, Reuters, and company statements
Talen Energy trades below replacement cost with nuclear and gas assets positioned for data center demand
Talen (TLN) operates ~13 GW including nuclear; recent trading levels and PJM focus align with pitch details
Aktis Oncology (AKTS) has miniprotein platform with Nectin-4 and B7-H3 programs and data expected in 2027
Company pipeline and clinical timelines match public disclosures and recent ASCO presentations
GEODNET has the world's largest RTK network with 21k+ nodes and major customers including John Deere and DJI
Network stats, coverage, and partnerships corroborated by project site and investor reports
MGM Japan Osaka casino alone could more than double the stock value
License approved; 2030 opening and EBITDA estimates are speculative without independent modeling
Notable Concerns
- Heavy reliance on presenter projections without external corroboration
- Real-time audience trading encouraged during pitches
Sources Consulted
- All-In's Best Ideas Pitch Competition: 4 Investors Present Their Top Trades Live
- All-In with Chamath, Jason, Sacks & Friedberg - All-In's Best Ideas Pitch Competition
- MGM Resorts: Barry Diller's People bids to buy casino giant
- Diller Plans a Takeover Bid for MGM Resorts
- Barry Diller's People bids for MGM Resorts, values casino operator at $18 billion
- Aktis Oncology Pipeline
- AKTIS ONCOLOGY INITIATES PHASE 1B CLINICAL TRIAL OF ITS NECTIN-4-TARGETING RADIOPHARMACEUTICAL PRODUCT CANDIDATE, AKY-1189
- Aktis Oncology - Next-generation precision radiopharmaceuticals
- GEODNET RTK Network
- Powering Data - Talen Energy
- Aaron Cowen Says $48 Bid Is a Floor, Japan Casino Could Add $50 Per Share
- Veteran Investor: Talen Energy Is a Double at Minimum ...